Literature DB >> 12829207

Reactivation of HBV replication in HIV-HBV infected patients.

Firouzé Bani-Sadr, Anne Maillard, Diane Ponscarme, Catherine Scieux, Jean Michel Molina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12829207     DOI： 10.1016/s0002-9343(03)00156-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  6 in total

1.  Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker.

Authors:  A J Chamorro; J L Casado; D Bellido; S Moreno
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

2.  Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors:  Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal:  BMC Infect Dis       Date:  2011-11-04       Impact factor: 3.090

3.  Hepatitis B reactivation after chemotherapy: two decades of clinical research.

Authors:  George K K Lau
Journal:  Hepatol Int       Date:  2008-03-05       Impact factor: 6.047

4.  Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.

Authors:  Bo Langhoff Hønge; Sanne Jespersen; Candida Medina; David da Silva Té; Zacarias José da Silva; Sharon Lewin; Lars Østergaard; Christian Erikstrup; Christian Wejse; Alex Lund Laursen; Henrik Krarup
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

5.  Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana.

Authors:  Bonolo Bonita Phinius; Motswedi Anderson; Resego Bokete; Tshepiso Mbangiwa; Wonderful Tatenda Choga; Kabo Baruti; Joseph Makhema; Rosemary Musonda; Jason T Blackard; Max Essex; Sikhulile Moyo; Richard Marlink; Simani Gaseitsiwe
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.889

6.  Immunogenicity and safety of 4 vs. 3 standard doses of HBV vaccination in HIV-infected adults with isolated anti-HBc antibody.

Authors:  Nattinee Laksananun; Jutarat Praparattanapan; Wilai Kotarathititum; Khuanchai Supparatpinyo; Romanee Chaiwarith
Journal:  AIDS Res Ther       Date:  2019-05-03       Impact factor: 2.250
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.